Thursday, Apr 09th
Last update07:00:18 AM GMT
Former U.S. President Bill Clinton and drugmakers Pfizer and Matrix Laboratories Ltd announced a deal on Thursday to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.
Second-line antiretroviral therapies and a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS will be made available at a reduced cost and in more convenient regimens, saving as many as hundreds of thousands of lives in the developing world.
 More than 3.1 million bottles of eye drops sold at major retailers, including Walgreens and CVS,... |
 The abortion rate is holding steady in the US despite total and partial bans in some... | ||
 The Supreme Court sided with a Christian counselor on Tuesday in her free speech challenge to... |
 A new COVID-19 variant, BA.3.2, has been detected in 25 states, according to a recent report... |
